CAPTRUST Financial Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-190
Closed -$8K – 2205
2022
Q2
$8K Buy
190
+49
+35% +$2.38K ﹤0.01% 3857
2022
Q1
$8K Sell
141
-13
-8% -$711 ﹤0.01% 3891
2021
Q4
$9K Buy
154
+82
+114% +$4.98K ﹤0.01% 3762
2021
Q3
$4K Hold
72
– – ﹤0.01% 4009
2021
Q2
$4K Hold
72
– – ﹤0.01% 3931
2021
Q1
$3K Buy
+72
New +$2.96K ﹤0.01% 3888

Other funds holding ATEX

CAPTRUST Financial Advisors's ATEX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Anterix (ATEX) in Q3 2022, closing a stake of 190 shares — an estimated $8K sold.

CAPTRUST Financial Advisors first reported a position in ATEX in Q1 2021 and held it in 6 quarters. The position peaked at $9K in Q4 2021. 100 funds tracked by Wall St. Rank hold ATEX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Anterix position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 190 Anterix shares in Q3 2022, an estimated $8K.
  • CAPTRUST Financial Advisors first reported a position in Anterix in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Anterix position peaked at $9K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Anterix as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.